Health Products

ETEST Antimicrobial Susceptibility Testing - Teicoplanin (2017-12-14)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
More than 10 numbers, contact manufacturer.ETEST Antimicrobial Susceptibility Testing - Teicoplanin
Manufacturer
BioMérieux S.A
376 Chemin De L'orme
Marcy-l'etoile
69280
FRANCE
412461

Introduction

Affected products

ETEST Antimicrobial Susceptibility Testing - Teicoplanin

Reason

Following an assessment of ETEST Teicoplanin with Staphylococcus Spp., It has been observed that even though the Minimum Inhibitory Concentration (MIC) essential agreement at +/- 1 dilution is less than 95% between ETEST TP256 and the reference method Agar Dilution (AD) for Staphylococcus Spp., an underestimation of MIC values by at least 1 dilution has been observed for coagulase negative Staphylococci (cons). This underestimation leads to a risk of false susceptible results linked, in particular to the lack of an intermediate category interpretation if EUCAST breakpoints are applied for this antibiotic. During the study, the false susceptible rate observed was 37.5% for cons, where strains with an MIC at 8 mg/ml, by the reference method (resistant) can be found susceptible by ETEST Teicoplanin.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime